Skip to content

RETRACTED: Long-term systemic treatment with lysergic acid diethylamide causes retinal damage in CD1 mice

H. Jiang, H. Xu

Human & Experimental Toxicology November 25, 2018 Retracted DOI: 10.1177/0960327118814162 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Controlled animal experiment Peer reviewed
Population CD1 mice
Intervention LSD
Dose 0.1 mg/kg or 0.2 mg/kg daily
Duration 2 months
Measures Electroretinography (ERG), Hematoxylin and eosin staining, Terminal deoxynucleotidyl transferase dUTP Nick end labeling (TUNEL) assay, Enzyme-linked immunosorbent assays, Real-time PCR, western blot
Topics LSD
Key findings Two months of daily low-dose LSD (0.1 or 0.2 mg/kg) in CD1 mice caused retinal damage, shown by decreased electroretinography responses and increased apoptotic photoreceptor cells. The authors attribute this to increased oxidative stress and inflammatory responses, suggesting these as potential mechanisms of LSD-induced retinal toxicity.

Abstract

As a classical hallucinogen with high potential for abuse, lysergic acid diethylamide (LSD) can cause long-lasting abnormalities in retina, but little is known about the exact mechanism. This study was to investigate effects of long-term systemic treatment of LSD at low dose on retinal damage and understand the underlying mechanisms. CD1 mice were treated intraperitoneally with 0.1 mg/kg or 0.2 mg/kg LSD daily for 2 months, mice treated with saline as negative control. Electroretinography (ERG) was used to test the retinal function after LSD treatment. Hematoxylin and eosin staining was used to show the retinal morphology and evaluate the loss of photoreceptor cells. Terminal deoxynucleotidyl transferase dUTP Nick end labeling (TUNEL) assay was used to detect the apoptotic cells. Enzyme-linked immunosorbent assays were used to show the oxidative stress and inflammatory response. Real-time PCR and western blot were applied to measure the gene and protein change to explore the underlying mechanisms. Results demonstrated that 2 months treatment with LSD caused retinal damage, evidenced by decreased ERG response and increased apoptotic photoreceptor cells through increasing oxidative stress and inflammatory response. Our study indicated that long-term systemic administration of LSD caused neurotoxic effects on retinas of CD1 mice, suggesting the potential mechanisms for the retina damage caused by LSD abuse.

Comparable studies

Other preclinical and animal studies on LSD, most cited first.

Study Year Design Participants
Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex Human embryonic kidney 293 cells stably expressing 5-HT2ARs; wild-type and 5-HT2AR... 2003 Experimental study
Evidence for a central 5‐hydroxytryptamine receptor stimulation by lysergic acid diethylamide Rats 1968 Experimental study
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression Rats 2020 Preclinical study
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission Male mice 2021 Multidisciplinary experimental study with in vivo electrophysiology, optogenetics, behavioral paradigms, molecular biology, and conditional knockout mice
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Mice and cultured rat cortical neurons 2023 Preclinical study

Citations in the library

Explore topics